Ronald Hafner

Ronald Hafner

Founder at NLS PHARMACEUTICS LTD.

Net worth: 316 733 $ as of 2024-04-29

60 year
Technology Services
Health Technology
Commercial Services

Profile

Mr. Ronald Hafner is a Partner at Deloitte Consulting GmbH and a Chairman at NLS Pharmaceutics Ltd.
He is on the Board of Directors at Covalo AG.
Mr. Hafner was previously employed as an Independent Director by Pingar Group Ltd., a Chief Executive Officer by Infosys Consulting AG, and a Chief Executive Officer & Partner by Lodestone Management Consultants AG.
He received his MBA from the University of Basel.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-05-04 2,399,491 ( 6.06% ) 316 733 $ 2024-04-29

Ronald Hafner active positions

CompaniesPositionStart
NLS PHARMACEUTICS LTD. Founder 2015-06-09
Deloitte Consulting GmbH Corporate Officer/Principal 2015-12-31
Director/Board Member -
All active positions of Ronald Hafner

Former positions of Ronald Hafner

CompaniesPositionEnd
Director/Board Member 2015-12-31
Chief Executive Officer -
Infosys Consulting AG Chief Executive Officer -
See the detail of Ronald Hafner's experience

Training of Ronald Hafner

University of Basel Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ronald Hafner's experience

Connections

23

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NLS PHARMACEUTICS LTD.

Health Technology

Private companies5
Deloitte Consulting GmbH

Technology Services

Infosys Consulting AG

Commercial Services

Technology Services

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW